"In other words, as we vaccinate 100 000 persons, we might save five lives but risk two to four deaths. This does not take into account the fact that
1. These passive pharmacovigilance data, different from the active reporting system of trials and observations, are notorious for underestimating casualties and side effects.6
2. Other severe side effects occur, such as myocarditis in young males who according to a recent study suffer a 13.6 fold risk of myocarditis.7
Thus, we have novel and worrying data that confirm the analysis we published in summer 2021, urging us to repeat our call for an installment of a European-wide active monitoring system that documents the safety and efficacy of COVID-19 vaccines long-term and for a rational public debate about the risk-benefit ratio of these novel vaccines"
Comments